XENASA Trademark

Trademark Overview

On Tuesday, July 19, 2022, a trademark application was filed for XENASA with the United States Patent and Trademark Office. The USPTO has given the XENASA trademark a serial number of 79348348. The federal status of this trademark filing is REGISTERED as of Tuesday, February 27, 2024. This trademark is owned by Tillotts Pharma AG. The XENASA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, for the diagnosis, prevention and/or treatment of gastrointestinal disorders and conditions; pharmaceutical preparation for the treatment of inflammation of the gastrointestinal tract; dietetic substances in the nature of dietetic foods adapted for medical use, namely, for the diagnosis, prevention and/or treatment of gastrointestinal disorders and conditions
xenasa

General Information

Serial Number79348348
Word MarkXENASA
Filing DateTuesday, July 19, 2022
Status700 - REGISTERED
Status DateTuesday, February 27, 2024
Registration Number7312317
Registration DateTuesday, February 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, for the diagnosis, prevention and/or treatment of gastrointestinal disorders and conditions; pharmaceutical preparation for the treatment of inflammation of the gastrointestinal tract; dietetic substances in the nature of dietetic foods adapted for medical use, namely, for the diagnosis, prevention and/or treatment of gastrointestinal disorders and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTillotts Pharma AG
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressCH
Party NameTillotts Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressCH
Party NameTillotts Pharma AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCH

Trademark Events

Event DateEvent Description
Thursday, August 25, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, August 30, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, September 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 6, 2022APPLICATION FILING RECEIPT MAILED
Thursday, May 4, 2023ASSIGNED TO EXAMINER
Thursday, May 4, 2023NON-FINAL ACTION WRITTEN
Monday, July 10, 2023REFUSAL PROCESSED BY IB
Friday, May 5, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 13, 2023REFUSAL PROCESSED BY MPU
Wednesday, June 14, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 31, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 31, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 31, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2023INTERNATIONAL REGISTRATION RENEWED
Wednesday, November 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 22, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, December 25, 2023NOTIFICATION PROCESSED BY IB
Wednesday, January 31, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 31, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, February 27, 2024REGISTERED-PRINCIPAL REGISTER
Sunday, February 18, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, February 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 28, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 28, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 2, 2024FINAL DISPOSITION PROCESSED
Saturday, July 20, 2024FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

xenasa treatment gastrointestinal disorders pharmaceutical dietetic conditions namely diagnosis prevention foods